Current status of endovascular treatment for dural arteriovenous fistulae in the anterior cranial fossa: A systematic literature review.
anterior cranial fossa
dural arteriovenous fistula
endovascular treatment
systematic review
Journal
International journal of medical sciences
ISSN: 1449-1907
Titre abrégé: Int J Med Sci
Pays: Australia
ID NLM: 101213954
Informations de publication
Date de publication:
2019
2019
Historique:
received:
01
09
2018
accepted:
04
12
2018
entrez:
13
2
2019
pubmed:
13
2
2019
medline:
6
6
2019
Statut:
epublish
Résumé
Anterior cranial fossa (ACF) dural arteriovenous fistulae (DAVFs) are rare, and a systematic review of the literature is lacking. Such a review is necessary, however, so a systematic PubMed search of related studies was performed. Twenty-four studies were identified, reporting on 48 patients, of whom 39 had definite age and sex information and 33 (84.6%, 33/39) were male. The afflicted patients were between 37 and 80 years old (mean 55.6). Among the 48 patients, 28 (58.3%, 28/48) primarily presented with intracranial hemorrhage, 47 (97.9%, 47/48) had feeding arteries from the anterior ethmoidal artery (AEA) of the ophthalmic artery (OA), and 40 (83.3%, 40/48) had bilateral feeding arteries. All of the cases had high-grade Cognard classifications (III-IV). Among the 48 patients, 43 (89.6%, 43/48) had drainage into the superior sagittal sinus (SSS). In addition, 36 (75%, 36/48) patients were treated via transarterial embolization (TAE). Of these patients, 28 (77.8%, 28/36) were managed via the AEA of the OA. Another 12 (25%, 12/48) patients were treated via transvenous embolization (TVE), 11 of whom (91.7%, 11/12) were treated with the trans-SSS approach. Complete angiographic cure was achieved in 44 (91.7%, 44/48) patients, with 4 (8.3%, 4/48) patients suffering from postprocedural complications. All 48 patients had clear descriptions of follow-up outcomes, with 45 (93.8%, 45/48) patients having a good outcome. Thus, when treating ACF DAVFs, endovascular treatment (EVT) can completely obliterate the fistula point and correct the venous shunting. EVT is therefore an effective treatment for ACF DAVF. Although many complications can occur, this approach achieves good outcomes in most cases.
Identifiants
pubmed: 30745800
doi: 10.7150/ijms.29637
pii: ijmsv16p0203
pmc: PMC6367520
doi:
Types de publication
Journal Article
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
203-211Déclaration de conflit d'intérêts
Competing Interests: The authors have declared that no competing interest exists.
Références
Clin Neurol Neurosurg. 1999 Mar;101(1):37-43
pubmed: 10350203
Neurol Med Chir (Tokyo). 1999 Apr;39(4):291-3
pubmed: 10358983
Neurosurgery. 1999 Oct;45(4):805-10; discussion 810-1
pubmed: 10515474
AJNR Am J Neuroradiol. 2000 Apr;21(4):761-5
pubmed: 10782792
Surg Neurol. 2002 Dec;58(6):410-6; discussion 416
pubmed: 12517625
Radiographics. 2004 Nov-Dec;24(6):1637-53
pubmed: 15537974
Neurol Med Chir (Tokyo). 2004 Oct;44(10):516-20; discussion 520-1
pubmed: 15633464
Neurosurgery. 2006 Oct;59(4):870-8; discussion 878-9
pubmed: 17038951
Neurosurgery. 2005 Oct;57(4):E809
pubmed: 17152660
Neurol Med Chir (Tokyo). 2007 Feb;47(2):70-3
pubmed: 17317944
Br J Neurosurg. 2007 Aug;21(4):414-6
pubmed: 17676466
J Neuroophthalmol. 2007 Dec;27(4):281-4
pubmed: 18090561
Neuroradiology. 2008 May;50(5):429-32
pubmed: 18189129
Neuroradiology. 2008 May;50(5):433-7
pubmed: 18288476
J Neurosurg. 2009 Jan;110(1):79-84
pubmed: 18847336
Neurol Med Chir (Tokyo). 2008 Dec;48(12):560-3
pubmed: 19106494
J Neuroimaging. 2010 Oct;20(4):382-5
pubmed: 19555408
BMJ. 2009 Jul 21;339:b2700
pubmed: 19622552
Neurol Med Chir (Tokyo). 2009 Sep;49(9):407-9
pubmed: 19779285
J Neurosurg. 2010 Mar;112(3):603-10
pubmed: 20192669
Neurol Med Chir (Tokyo). 2010;50(3):217-20
pubmed: 20339271
Interv Neuroradiol. 2008 Dec 29;14(4):415-27
pubmed: 20557741
Interv Neuroradiol. 1997 Sep 30;3(3):239-45
pubmed: 20678429
Clin Neurol Neurosurg. 2010 Dec;112(10):903-8
pubmed: 20727670
Surg Radiol Anat. 1990;12(4):293-7
pubmed: 2096466
Neurol Med Chir (Tokyo). 2010;50(11):995-7
pubmed: 21123984
Neurol Med Chir (Tokyo). 2011;51(1):40-4
pubmed: 21273743
Interv Neuroradiol. 2011 Mar;17(1):93-103
pubmed: 21561565
Neurosurg Clin N Am. 2012 Jan;23(1):55-62
pubmed: 22107858
Neurosurgery. 2012 Dec;71(2 Suppl Operative):ons269-73; discussion ons273
pubmed: 22791037
J Clin Neurosci. 2013 Feb;20(2):287-91
pubmed: 23219832
J Neurointerv Surg. 2014 Mar;6(2):115-20
pubmed: 23416785
Neurol Sci. 2013 Oct;34(10):1851-3
pubmed: 23423466
J Neurointerv Surg. 2014 May;6(4):281-5
pubmed: 23468536
J Neurointerv Surg. 2014 Apr 1;6(3):195-9
pubmed: 23525571
Neuroradiol J. 2007 Jun 30;20(3):348-54
pubmed: 24299680
Clin Neurol Neurosurg. 2014 Feb;117:1-5
pubmed: 24438796
J Neurointerv Surg. 2015 Apr;7(4):e15
pubmed: 24682847
Interv Neuroradiol. 2015 Apr;21(2):244-8
pubmed: 25964442
J Clin Neurosci. 2015 Dec;22(12):1969-72
pubmed: 26234634
J Neurointerv Surg. 2016 Sep;8(9):954-8
pubmed: 26323794
Expert Rev Neurother. 2016;16(3):307-18
pubmed: 26832225
Clin Anat. 2016 Sep;29(6):718-28
pubmed: 27148680
World Neurosurg. 2016 Sep;93:94-9
pubmed: 27241099
Interv Neuroradiol. 2016 Oct;22(5):548-56
pubmed: 27306522
Neurosurg Rev. 2018 Apr;41(2):391-398
pubmed: 27426100
Int J Med Sci. 2016 Oct 17;13(10):790-799
pubmed: 27766029
Acta Neurochir (Wien). 2017 May;159(5):823-830
pubmed: 28197790
No Shinkei Geka. 2017 Jul;45(7):591-598
pubmed: 28720741
Interv Neuroradiol. 2017 Dec;23(6):661-665
pubmed: 28975855
World Neurosurg. 2018 Feb;110:e786-e793
pubmed: 29180085
Biomed Rep. 2018 Jan;8(1):17-25
pubmed: 29399335
Radiol Case Rep. 2018 Jun 01;13(5):1036-1041
pubmed: 30228839
J Neurosurg. 1995 Feb;82(2):166-79
pubmed: 7815143
Acta Neurochir (Wien). 1994;129(3-4):146-51
pubmed: 7847155
Radiology. 1995 Mar;194(3):671-80
pubmed: 7862961
Neuroradiology. 1996 Apr;38(3):252-3
pubmed: 8741197
J Neurosurg. 1997 Feb;86(2):291-3
pubmed: 9010433